- Joined
- 9 May 2020
- Messages
- 7,393
- Reaction score
- 136
- Country
If you mean the empty containers ready for the vaccines, I would agree with you.Supply of vials isn't dependent on the results of clinical trials,
And those empty vials are already produced for all the other vaccines, so are irrelevant.
However, if you mean the vials full of vaccine, then you're talking utter nonsense. You can't manufacture the vaccine to go into the vials until the clinical trials have been completed. Well, you could, but it might all be a totally wasted effort, financially and physically, and you might be left with copious amounts of dangerous vaccines. And that effort would be well spent elsewhere.
I'm afraid the AZ CEO doesn't have a great deal of reliability.supply of the materials and chemicals used in the manufacture of the vaccine isn't dependent on clinical trials. Yet when you have an order in place and advance funding agreed to support this supply of materials and production capacity, you can get on with arranging it and ordering it earlier. This is exactly what happened with the AZ vaccine, as explicitly stated by the AZ CEO.
Unless, what he said about the UK contract restricting the supply of vaccine to EU was correct. Then the UK was to blame.
Then if he lied to the EU about there being no other contract that would be limit the supply to EU. Then both UK and AZ were to blame.
Because they were approved earlier, and for no other reason, You can't use the vaccine until it has been approved, irrespective of when the contract was agreed.It's amazing how you think that signing of contract is irrelevant, but the fact remains that both vaccines that the UK signed deals for earlier than the EU were supplied to the UK earlier and in people's arms earlier.